To evaluate the impact of vorasidenib on health-related quality of life (HRQoL), neurocognition and seizure activity.
No takes yet. Share an insight, caveat, or question.
Peters et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: